OMER Omeros Corporation PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Omeros (OMER) Stock: Buy, Sell, or Hold?

$18.15
+0.85 (+4.91%) ▲
5d: -0.17% 30d: -3.87% 90d: +4.61%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (90%)
Quality Score
64/100
Position
FAIR
30-Day Fair Range
$16.79 – $18.92
Position: FAIR
Forward P/E & Valuation
14.8x CHEAP
vs 56.8x historical avg
Wall Street Target
$27.50
+51.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$16.64 / $19.28
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: OMER shows positive signals but monitor for confirmation. Market pricing in 36.2% decline. Moderate conviction.
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Nov 9, 2026 at $17.51 · last confirmed Nov 9, 2026

Strength: 5.8/10

Get Alerted When OMER Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$59.88
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$37.18
51.2% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: OMER is currently trading at $18.15, which is considered fair relative to its 30-day fair value range of $16.79 to $18.92. From a valuation perspective, the stock is trading at a discount (Forward PE: 14.8) compared to its historical average (56.8). Remarkably, the market is currently pricing in an annual earnings decline of 36.2% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, OMER is in a strong uptrend. Immediate support is located at $16.64, while resistance sits at $19.28. The stock is showing strong short-term momentum, up 4.9% recently.

Market Sentiment: OMER scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $27.50 (+51.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $16.79 - $18.92
Company Quality Score 64/100 (BUY)
Volume Confirmation HIGH
Confidence Score 90.4%

Trading Range & Key Levels

30-Day Trading Range $16.79 - $18.92
Current vs Trading Range FAIR
Expected Move (7 Days) ±$1.84 (10.1%)
Support Level $16.64
Resistance Level $19.28
Current Trend Strong Uptrend
Technical data as of Nov 11, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BULLISH: Options cheap (IV 0th percentile)
  • BULLISH: Strong technical setup (67/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+4.9%)
  • BULLISH: Trading 51.5% below Wall St target ($27.50)
  • BULLISH: Bottoming setup score 67/100 — corrected, stabilizing, and turning up

Fundamental Context

Forward P/E (Next Year Est.) 14.76
Wall Street Target $27.50 (+51.5%)
Revenue Growth (YoY) 14.9%
Profit Margin 324.9%
Valuation Discount vs History -36.2% cheaper
PE vs Historical 14.8 vs 56.8 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -36.2% (market-implied from PE analysis)
1-Year Target $16.34 (-10%)
2-Year Target $14.70 (-19%)
3-Year Target $13.23 (-27%)
3-Yr Target (if PE normalizes) (PE: 15→57) $50.93 (+181%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: 78.3%) $82.44 (+354%)
Base: (SPY PE: 14.8, Growth: 78.3%) $61.26 (+238%)
Bear: (PE: 12.5, Growth: 78.3%) $52.07 (+187%)
📈 Valuation based on Current Earnings
Trailing PE: 14.18 | Current EPS (TTM): $1.22
Bull Case $19.19 (+6%)
Analyst growth 0.8%, PE expands to 15.6
Base Case $17.44 (-4%)
Market implied 0.8%, PE stable at 14.2
Bear Case $11.76 (-35%)
Severe decline -20.0%, PE contracts to 12.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.8 to 56.8
Stabilization Target: $69.86 (+284.9%)
PE Expansion Potential: +284.9%
Share OMER Analysis

Share this live OMER analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (OMER)

Bullish 3 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary: Bullish sentiment on StockTwits regarding $OMER's chart predictions and the potential impact of a lawsuit against dialysis companies on the stock.
Key Retail Themes: Stock price prediction Legal action against dialysis companies
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:29 AM ET
Data refreshes hourly during market hours. Next update: 3:29 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for OMER.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
PRAX
Praxis Precision Medicin…
STRONG BUY
21 analysts
$650 38 SELL
NAMS
NewAmsterdam Pharma Comp…
STRONG BUY
16 analysts
$50 44 HOLD
IMUX
Immunic Inc
STRONG BUY
13 analysts
$43 51 HOLD
ACAD
ACADIA Pharmaceuticals I…
STRONG BUY
20 analysts
$31 43 HOLD
DYN
Dyne Therapeutics Inc
STRONG BUY
17 analysts
$34 39 SELL

Advanced OMER Option Strategies

Professional options setups generated by AI based on today's OMER price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive OMER Research Pages
OMER Technical Chart OMER Price Prediction OMER Intrinsic Value DCF OMER Earnings Date Why is OMER Moving Today? OMER Investment Advisor OMER Fair Price Analyzer OMER Options Chain OMER Options Advisor OMER Options Analysis OMER Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals